MerLion Pharma
Singapore · Founded 2002
About MerLion Pharma
MerLion Pharmaceuticals.drug discovery and development company, engages in the research and development of natural products. It operates through two business units, MerLion Research and MerLion Development. The MerLion Research unit is a contract services business, which provides access to natural product collections by offering sample/extract supply services, extract profiling and standardization, assay development, throughput screening, compound purification and structural identification, biocatalyst isolation, and strain improvement. The MerLion Development unit is progressing finafloxacin, a differentiated antibacterial candidate through phase II clinical trials, which is targeted initially for the eradication of Helicobacter pylori and treatment of urinary tract infections. It also provides portfolio of earlier-stage, preclinical antibacterial, and oncology programmes. The company serves pharmaceutical, industrial biotechnology, agro science, food and flavorings, cosmetics, and personal healthcare companies. MerLion Pharmaceuticals Pte. Ltd. was founded in 2002 and is based in Singapore, Singapore with clinical development operations in Berlin, Germany.
Company Facts
- Founded: 2002
- Legal name: MerLion Pharmaceuticals GmbH
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $50.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2010)
- Website: merlionpharma.com
- Phone: (65) 66928002
Social Profiles
Canonical: https://fsome.com/organization/merlion-pharma-8253868 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.